The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Dozens of protesters gathered outside the practice of a suburban Minneapolis dentist who killed a protected lion in Zimbabwe.
Ramsay Street, the set of long-running Australian soap Neighbours, is to be transformed into a hotel for fans.
The average Brit spends almost ten years of their lives in front of the television, research has suggested.